US Patent 7279550 Irreversible cysteine protease inhibitors of legumain
Patent 7279550 was granted and assigned to Probiodrug on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+193 characters)
Article
Patent abstract
Presented are compounds represented by the following general formulas (I) and (II), for inhibiting cysteine protease legumain for modulating associated disease states in subjects
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07279550 Irreversible cysteine protease inhibitors of legumain US Patent 7279550 Irreversible cysteine protease inhibitors of legumain
Infobox
Patent Number
0727955000
Patent Number
727955000
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072795500
Date of Patent
October 9, 2007
0Patent Application Number
104857230
Date Filed
July 23, 2002
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072795500
Date of Patent
October 9, 2007
0Patent Application Number
104857230
Date Filed
July 23, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07279550 Irreversible cysteine protease inhibitors of legumain
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07279550
Date of patent
October 9, 2007
Patent application number
10485723
Date Filed
July 23, 2002
Patent primary examiner
Find more entities like US Patent 7279550 Irreversible cysteine protease inhibitors of legumain
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.